tetraethylammonium has been researched along with Osteogenic Sarcoma in 3 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pelagalli, A | 1 |
Nardelli, A | 1 |
Fontanella, R | 1 |
Zannetti, A | 1 |
Kawase, T | 1 |
Burns, DM | 1 |
Richter, C | 1 |
Ferrier, J | 1 |
3 other studies available for tetraethylammonium and Osteogenic Sarcoma
Article | Year |
---|---|
Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells.
Topics: Aquaporin 1; Bone Marrow Cells; Bone Neoplasms; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Mo | 2016 |
Calcitonin gene-related peptide stimulates potassium efflux through adenosine triphosphate-sensitive potassium channels and produces membrane hyperpolarization in osteoblastic UMR106 cells.
Topics: Adenosine Triphosphate; Animals; Calcitonin Gene-Related Peptide; Colforsin; Enzyme Inhibitors; Glyb | 1998 |
Continuously active sodium channels in osteoblastic ROS 17/2.8 cells.
Topics: Animals; Calcium; Conductometry; Membrane Potentials; Nifedipine; Osteoblasts; Osteosarcoma; Rats; S | 1991 |